Nantahala Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Nantahala Capital Management’s Portfolio TFFP Stock Details TFFP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,843	Closed	-$2.09M	–	146
2021 Q3	$2.09M	Sell	10,843 -3,870	-26%	-$821K	0.07%	105
2021 Q2	$3.54M	Sell	14,713 -589	-4%	-$162K	0.1%	99
2021 Q1	$5.19M	Sell	15,302 -55,237	-78%	-$22.5M	0.15%	81
2020 Q4	$25.3M	Sell	70,539 -10,781	-13%	-$4.15M	0.78%	35
2020 Q3	$37.5M	Buy	81,320 +47,059	+137%	+$13.3M	1.15%	17
2020 Q2	$4.93M	Buy	34,261 +11,092	+48%	+$1.4M	0.15%	86
2020 Q1	$2.22M	Buy	23,169 +2,169	+10%	+$258K	0.08%	90
2019 Q4	$2.81M	Buy	+21,000	New	+$2.69M	0.09%	79

Other funds holding TFFP

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PCM

Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

Nantahala Capital Management's TFFP Position: Q4 2021 in Review

Nantahala Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2021, closing a stake of 10,843 shares — an estimated $2.09M sold.

Nantahala Capital Management first reported a position in TFFP in Q4 2019 and held it in 8 quarters. The position peaked at $37.5M in Q3 2020. 51 funds tracked by Wall St. Rank hold TFFP as of Q4 2021.

Nantahala Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Nantahala Capital Management sold 10,843 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $2.09M.
Nantahala Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
Nantahala Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $37.5M in Q3 2020.
51 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Nantahala Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.